Overview
Chang Lu practices practicing medicine in Guangzhou, China.
Mr. Lu is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Inflammatory Myofibroblastic Tumor, and Lung Adenocarcinoma.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chang Lu
Is Chang Lu a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Chang Lu is classified as an Advanced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chang Lu participate in research or clinical trials?
Yes. Chang Lu has published 24 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Chang Lu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Lu isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Ataxia-TelangiectasiaMr. Lu isExperienced. Learn about Ataxia-Telangiectasia.
- EGFR Positive Lung CancerMr. Lu isExperienced. Learn about EGFR Positive Lung Cancer.
- Inflammatory Myofibroblastic Tumor
- Lung AdenocarcinomaMr. Lu isExperienced. Learn about Lung Adenocarcinoma.
- PIK3CA-Related Overgrowth Spectrum